Patents

Mary Kay’s Topical with Vinca Major Provides Reduction of Melanin Production

Formulation detailed in US Patent No. 11,607,380 B2 also increases antioxidant activity.

US Patent No. 11,607,380 B2 (Tiffany Florence, David Gan, Michelle Hines); Mary Kay Inc., Addison, TX, has patented a method for treating skin by topically applying a composition that is comprised an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Vinca major. The composition reduces melanin production in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters